• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AGTR1、TFAP2B和TRAF1中的单核苷酸多态性与日本早产儿动脉导管未闭的发生率无关。

Single nucleotide polymorphisms in AGTR1, TFAP2B, and TRAF1 are not associated with the incidence of patent ductus arteriosus in Japanese preterm infants.

作者信息

Kawase Koya, Sugiura Tokio, Nagaya Yoshiaki, Yamada Takaharu, Sugimoto Mari, Ito Koichi, Togawa Takao, Nagasaki Rika, Kato Takenori, Kouwaki Masanori, Koyama Norihisa, Saitoh Shinji

机构信息

Department of Pediatrics and Neonatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Department of Pediatrics, Toyohashi Municipal Hospital, Aichi, Japan.

出版信息

Pediatr Int. 2016 Jun;58(6):461-6. doi: 10.1111/ped.12861. Epub 2016 Feb 3.

DOI:10.1111/ped.12861
PMID:26615960
Abstract

BACKGROUND

Persistent patent ductus arteriosus (PDA) is a frequent complication in preterm infants. Single nucleotide polymorphisms (SNP) in several genes, including angiotensin II receptor, type 1 (AGTR1), transcription factor AP-2 beta (TFAP2B) and tumor necrosis factor receptor-associated factor 1 (TRAF1), have been reported to be associated with PDA in preterm infants. The aim of this study was to evaluate the relationships between PDA in preterm infants and polymorphisms in AGTR1, TFAP2B and TRAF1 in the Japanese population.

METHODS

The subjects consisted of 107 preterm infants with gestational age <32 weeks. Extremely low-birthweight infants were treated with prophylactic indomethacin during the first 24 h after birth. Five SNP, namely, rs5186 in AGTR1, rs987237 and rs6930924 in TFAP2B, and rs1056567 and rs10985070 in TRAF1, were genotyped using TaqMan SNP genotyping assays.

RESULTS

There were no significant differences in the distributions of the genotypes and allele frequencies of all studied SNP between the PDA group (n = 46) and the non-PDA group (n = 61).

CONCLUSIONS

There were no significant associations between the studied SNP and the incidence of PDA in Japanese preterm infants. These SNP may not be clinically important predisposing factors for PDA in Japanese preterm infants.

摘要

背景

持续性动脉导管未闭(PDA)是早产儿常见的并发症。据报道,包括血管紧张素II受体1型(AGTR1)、转录因子AP-2β(TFAP2B)和肿瘤坏死因子受体相关因子1(TRAF1)在内的多个基因中的单核苷酸多态性(SNP)与早产儿PDA有关。本研究的目的是评估日本人群中早产儿PDA与AGTR1、TFAP2B和TRAF1基因多态性之间的关系。

方法

研究对象包括107例孕周<32周的早产儿。极低出生体重儿在出生后24小时内接受预防性吲哚美辛治疗。使用TaqMan SNP基因分型检测对AGTR1中的rs5186、TFAP2B中的rs987237和rs6930924以及TRAF1中的rs1056567和rs10985070这5个SNP进行基因分型。

结果

PDA组(n = 46)和非PDA组(n = 61)之间,所有研究SNP的基因型和等位基因频率分布均无显著差异。

结论

在日本早产儿中,所研究的SNP与PDA的发生率之间无显著关联。这些SNP可能不是日本早产儿PDA的重要临床易感因素。

相似文献

1
Single nucleotide polymorphisms in AGTR1, TFAP2B, and TRAF1 are not associated with the incidence of patent ductus arteriosus in Japanese preterm infants.AGTR1、TFAP2B和TRAF1中的单核苷酸多态性与日本早产儿动脉导管未闭的发生率无关。
Pediatr Int. 2016 Jun;58(6):461-6. doi: 10.1111/ped.12861. Epub 2016 Feb 3.
2
Determination of genetic predisposition to patent ductus arteriosus in preterm infants.早产儿动脉导管未闭遗传易感性的测定。
Pediatrics. 2009 Apr;123(4):1116-23. doi: 10.1542/peds.2008-0313.
3
Interactions between PDA-associated polymorphisms and genetic ancestry alter ductus arteriosus gene expression.PDA 相关多态性与遗传背景的相互作用改变动脉导管基因表达。
Pediatr Res. 2022 Mar;91(4):903-911. doi: 10.1038/s41390-021-01506-6. Epub 2021 Apr 9.
4
Familial nonsyndromic patent ductus arteriosus caused by mutations in TFAP2B.由TFAP2B基因突变引起的家族性非综合征型动脉导管未闭。
Pediatr Cardiol. 2011 Oct;32(7):958-65. doi: 10.1007/s00246-011-0024-7. Epub 2011 Jun 4.
5
Angiotensin II type 1 receptor A1166C polymorphism and prophylactic indomethacin treatment induced ductus arteriosus closure in very low birth weight neonates.血管紧张素II 1型受体A1166C基因多态性与预防性吲哚美辛治疗诱导极低出生体重儿动脉导管闭合
Pediatr Res. 2003 Nov;54(5):753-5. doi: 10.1203/01.PDR.0000088016.67117.39. Epub 2003 Aug 6.
6
The effect of hemodynamically significant patent ductus arteriosus on acute kidney injury and systemic hypertension in extremely low gestational age newborns.血流动力学显著的动脉导管未闭对极早早产儿急性肾损伤和系统性高血压的影响。
J Matern Fetal Neonatal Med. 2019 Oct;32(19):3209-3214. doi: 10.1080/14767058.2018.1460349. Epub 2018 Apr 12.
7
Genetic variants associated with patent ductus arteriosus in extremely preterm infants.与极早产儿动脉导管未闭相关的遗传变异。
J Perinatol. 2019 Mar;39(3):401-408. doi: 10.1038/s41372-018-0285-6. Epub 2018 Dec 5.
8
Incidence and risk factors associated with the patency of ductus arteriosus in preterm infants with respiratory distress syndrome in Kuwait.科威特患有呼吸窘迫综合征的早产儿动脉导管未闭的发生率及相关危险因素。
Saudi Med J. 2003 Sep;24(9):982-5.
9
Management of patent ductus arteriosus in preterm infants.早产儿动脉导管未闭的管理
Anadolu Kardiyol Derg. 2006 Mar;6(1):28-33.
10
Perinatal factors in patent ductus arteriosus in very low-birthweight infants.极低出生体重儿动脉导管未闭的围产期因素
Pediatr Int. 2014 Feb;56(1):72-6. doi: 10.1111/ped.12199.

引用本文的文献

1
Novel drug targets for ductus arteriosus manipulation: Looking beyond prostaglandins.用于动脉导管操纵的新型药物靶点:超越前列腺素。
Semin Perinatol. 2018 Jun;42(4):221-227. doi: 10.1053/j.semperi.2018.05.004. Epub 2018 May 10.
2
Identification of differentially regulated genes in human patent ductus arteriosus.人类动脉导管未闭中差异表达基因的鉴定
Exp Biol Med (Maywood). 2016 Dec;241(18):2112-2118. doi: 10.1177/1535370216661778. Epub 2016 Jul 28.